Tag: VRCA

Verrica Pharmaceuticals Delivers Strong Q4 Financial Results Verrica Pharmaceuticals (NASDAQ: VRCA) recently announced its fourth-quarter financial results, showcasing impressive earnings ...

As of January 29, 2024, Verrica Pharmaceuticals has successfully obtained a permanent J-Code (J7354) for their innovative product, YCANTH™, from ...